BoneSmart® Hip / Knee Replacement Forum
Joint Replacement Patient Advocacy
and Online Community
  1. RATE YOUR SURGEON ON OUR NEW JOINT SURGEON LOCATOR

    Your opinion matters so please click on this announcement to find out how to rate the surgeons you have worked with

    You could also go to the Surgeon Locator via the blue nav bar at the top - find the tab "Surgeon Locator"

    Dismiss Notice

Metal on Metal Pseudotumors are Common in Well Positioned, Low Wearing Retrieved Metal-on-Metal Hip Arthroplasties

Discussion in 'Allergies and MoM articles' started by Josephine, May 4, 2016.

  1. Josephine

    Josephine FORUM ADMIN, NURSE DIRECTOR Administrator
    Thread Starter

    Member Since:
    Jun 8, 2007
    Age:
    77
    Messages:
    84,611
    Gender:
    Female
    Location:
    The North
    Country:
    United Kingdom United Kingdom
    Pseudotumors are Common in Well Positioned, Low Wearing Retrieved Metal-on-Metal Hip Arthroplasties PAPER NO. 304
    Ashley Matthies, BSc, London, United Kingdom
    Johann Henckel, BM, London, United Kingdom
    John Skinner, FRCS, London, United Kingdom
    Alister Hart, FRCS, London, United Kingdom


    INTRODUCTION: Pseudotumors are sterile inflammatory lesions found in the soft tissues surrounding metal-on-metal (MOM) hip arthroplasties. These lesions are thought to represent an adverse tissue response to metal wear debris and may explain the high rates of failure widely cited in the current literature. However, the etiology remains unclear, with recent studies suggesting that pseudotumors can occur in patients with well functioning prostheses. We sought to investigate further the relationship between pseudotumors, wear rate and component orientation in a large series of retrieved MOM hips.

    METHODS: We performed a well-powered study of 105 consecutively revised patients with current generation large diameter MOM hip arthroplasties. We performed both cross-sectional and matched case-control analyses to compare component position, pre-revision blood metal ion levels and component wear rates between two groups of patients according to findings on metal artefact reduction sequence (MARS) MRI scanning. Patients demonstrating evidence of a pseudotumour were compared with those that did not (Table 1). Component wear was measured in our retrieval laboratory using a roundness measuring machine.

    RESULTS: In this series, 69% of patients demonstrated a pseudotumor on pre-revision MARS MRI. No significant differences were observed for whole blood metal ion levels or component wear rates when patients with pseudotumors were compared to those without (Table 2). Additionally, patients with well-positioned hips demonstrated a similar prevalence of pseudotumors as those with cup positions outside of Lewinnek’s ‘safe zone’ (67% and 66% respectively, p = 0.64). The distribution of pseudotumors according to cup position is shown in Figure 1.

    DISCUSSION AND CONCLUSION: Pseudotumors were commonly diagnosed prior to revision of current generation MOM hip arthroplasties, but were not associated with component malposition, raised blood metal ion levels or high component wear rates. This would suggest that patient specific factors are likely to be more influential in the aetiology of adverse tissue reactions in patients with MOM hip arthroplasty.

    Table 1. Demographic and clinical data for each of the study groups: (1) No Pseudotumor, (2) Pseudotumor, (3) Matched Pseudotumor
    1.JPG

    Table 2. Results for whole blood (WB) metal ion levels and component wear rates for the matched case-control comparison.
    2.JPG
     

Share This Page